Samsung Biologics is pursuing its mission to create a better world with high-quality biopharmaceuticals through a global logistics supply chain and comprehensive social responsibilities, while building a basis for sustainability. As a response to climate change, Samsung Biologics will expand its eco-friendly investment in the production facilities and energy reduction in the business sites, while also engaging in the Carbon Disclosure Project (CDP). Moreover, we will grow with the local community through various social contribution activities such as supporting the the most vulnerable members of our local community, and fulfilling social environmental responsibilities by participating in the Korea National Institue for Bioprocessing Research & Training (K-NIBRT) to establish the Shared Growth Management.
Sustainability Report 2021
Report Overview
Samsung Biologics creates social values across economic, social, and environmental sectors and published its first Sustainability Report in 2021 to transparently share with its stakeholders its sustainability performances. We will annually disclose the company’s performance and activities in a transparent manner through the publication of this report, and gather options from various stakeholders to apply it to our business management and enhance the effectiveness of sustainable management activities.
Reporting Period
This report covers economic, social, and environmental performance and activities from January 1, 2020 to December 31, 2020, in addition to some achievements that may include information dating up to the first half of 2021. Quantitative data for the late three fiscal years from 2018 to 2020 (with some environmental data from 2017 to 2020) has been provided to allow for trend analysis over time.
Reporting Standards
This report was prepared in accordance with the Core option of the Global Reporting Initiative (GRI) standards. It also used ISO 26000, UN Global Compact principles, <IR> Framework, SASB information disclosure standards, and TCFD recommendations as references.
Reporting Scope
This report covers the sustainability activities and performances of all domestic and international businesses. Financial performance data is based upon consolidated K-IFRS. In addition to financial information, non-financial information has followed the formal disclosure system and has been prepared in accordance with the fiscal year. The data related to energy usage and greenhouse gas emissions was prepared in accordance with the results of the emission verification.



Thank you for Subscribing to Our Newsletter

아래 다운로드 버튼을 클릭하시면 바로 다운로드 하실 수 있습니다.


Subscribe to Our Newsletter

파일 다운로드를 위해 뉴스레터 구독용 이메일 주소를 입력해주세요.
* 구독자라면 구독중인 이메일 주소를 입력해주세요.

뉴스레터 구독 서비스 유무 확인

Subscribe to Our Newsletter

뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.

Subscribe to Our Newsletter
    • - 개인정보 수집 목적 : 이메일 발신서비스 제공
    • - 개인정보 수집 항목 : 이메일 주소, 회사명, 이름, 직급, 국가
    • - 이용 및 보관 기간 : 이메일 발신서비스 해지 시까지

    개인정보 수집에 동의하지 않을 시, 뉴스레터 서비스를 이용할 수 없습니다.

    삼성바이오로직스 개인정보 보호정책에 따라 개인정보는 안전하게 관리됩니다.



Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.

Copyright Samsung Biologics. All rights reserved